APPLICATION
ANDA062825
TYPE
ANDA
ORIGINAL APPROVAL
1987-10-23
LATEST ACTION
1997-07-22
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ERYTHROMYCINDiscontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
1997-07-22Labeling · Supplement 6AP
1994-08-17Labeling · Supplement 4AP
1994-06-28Manufacturing (CMC) · Supplement 5AP
1992-03-16Labeling · Supplement 3AP
1992-02-14Labeling · Supplement 2AP
1991-03-06Labeling · Supplement 1AP
1987-10-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.